Momegalen Fett (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momegalen Fett, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and immune responses in various dermatologic conditions such as psoriasis, eczema, atopic dermatitis and contact dermatitis.

GNH USA supplies Momegalen Fett as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under strict quality‑assurance standards. The company ensures consistent batch release, documentation and regulatory alignment with EU market requirements.

Momegalen Fett (mometasone furoate) is a topical corticosteroid used to manage inflammatory skin disorders. - Psoriasis: reduces plaque formation and erythema, improving skin appearance. - Eczema: alleviates itching and inflammation, promoting lesion healing. - Atopic dermatitis: controls flare‑ups and decreases skin redness. - Contact dermatitis: diminishes allergic skin reactions and swelling.

Topical application of Momegalen Fett may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning sensation: mild transient feeling at the application site. - Pruritus: itching that may occur after use. - Dryness: skin becomes dry or flaky. - Erythema: mild redness of the treated area.

Serious or Rare Side Effects: - Skin atrophy: thinning of the skin with prolonged use. - Telangiectasia: visible small blood vessels developing on the skin. - Hypothalamic‑pituitary‑adrenal suppression: systemic cortisol reduction with extensive application.

Before prescribing Momegalen Fett, clinicians should consider several precautionary measures to ensure safe use. - Application area: limit to affected skin and avoid large surface areas. - Duration of therapy: use for the shortest effective period to reduce risk of adverse effects. - Concomitant infections: avoid use on skin with bacterial, viral or fungal infections unless treated. - Occlusive dressings: do not cover treated area with airtight dressings unless directed. - Pediatric use: exercise caution in children due to higher skin absorption. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Momegalen Fett can interact with other agents, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of hypothalamic‑pituitary‑adrenal suppression. - CYP3A4 inhibitors: potent inhibitors (e.g., ketoconazole) may raise local drug levels.

Moderate Interactions (Monitor Closely): - Antifungal agents: topical azoles may alter skin barrier and affect absorption. - Immunosuppressants: combined effect may enhance immunosuppression. - Phototherapy: may increase skin sensitivity when used together.